about
Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infectionCD4 depletion in SIV-infected macaques results in macrophage and microglia infection with rapid turnover of infected cellsIdentification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific elispot-based cytotoxic T-lymphocyte responses for AIDS vaccine designIdentification of a protective CD4+ T-cell epitope in p15gag of Friend murine leukemia virus and role of the MA protein targeting the plasma membrane in immunogenicityCharacterization of human immunodeficiency virus type 1 (HIV-1) Gag- and Gag peptide-specific CD4(+) T-cell clones from an HIV-1-seronegative donor following in vitro immunizationThe functional CD8 T cell response to HIV becomes type-specific in progressive disease.Discordant outcomes following failure of antiretroviral therapy are associated with substantial differences in human immunodeficiency virus-specific cellular immunity.CD127+CCR5+CD38+++ CD4+ Th1 effector cells are an early component of the primary immune response to vaccinia virus and precede development of interleukin-2+ memory CD4+ T cells.Depletion of CD4⁺ T cells abrogates post-peak decline of viremia in SIV-infected rhesus macaquesViral load and CD4+ T-cell dynamics in primary HIV-1 subtype C infection.Race between retroviral spread and CD4+ T-cell response determines the outcome of acute Friend virus infection.Decreased frequency of cytomegalovirus (CMV)-specific CD4+ T lymphocytes in simian immunodeficiency virus-infected rhesus macaques: inverse relationship with CMV viremia.Immune reconstitution in human immunodeficiency virus type 1-infected children with different virological responses to anti-retroviral therapy.IL-21R on T cells is critical for sustained functionality and control of chronic viral infection.
P2860
Q24536249-08A87D15-73A4-4BDD-8D4D-62140E5AAD71Q27322949-AC89A667-C5E3-4F77-9E79-61F94221B601Q33845527-D6DD7FC7-7429-4C67-BE08-E3AFCC343650Q34186587-D4E07C42-AA38-4610-A714-A1B31C0B8FF5Q34342413-6403010D-8A13-4F56-980A-7A0B12612E60Q34815358-38F93928-117A-41BC-822F-93F75735928EQ34976619-FFD786B1-2FDB-4780-9825-E4721187BDB4Q35101557-96896E39-414E-4408-8CB1-69260F3CC678Q35484743-72BEE7D5-2F9B-4C83-9221-7F295232C21CQ37240053-94553134-CDAE-4213-B33E-80951D641CDFQ37410816-5FD06CFB-BF0E-4644-9A8F-9DA5E18814CEQ39683300-340B1A9A-72CC-437B-BD56-C275E56AF7F5Q45399547-EDC08004-FF31-46A6-AF40-6A649F4F3143Q46697142-FBC9DE7D-B9B1-40B4-A6E3-F158FA2466F1
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The CD4(+) T cell response to HIV-1.
@ast
The CD4(+) T cell response to HIV-1.
@en
type
label
The CD4(+) T cell response to HIV-1.
@ast
The CD4(+) T cell response to HIV-1.
@en
prefLabel
The CD4(+) T cell response to HIV-1.
@ast
The CD4(+) T cell response to HIV-1.
@en
P1476
The CD4(+) T cell response to HIV-1.
@en
P2093
P304
P356
10.1016/S0952-7915(00)00104-7
P577
2000-08-01T00:00:00Z